Assessing the diversity and determinants of health‐related quality of life measures in patients with acute heart failure

Abstract Aims Heart failure with reduced ejection fraction (HFrEF) significantly impacts health‐related quality of life (HR‐QoL). Existing HR‐QoL questionnaires can show inconsistencies, potentially misrepresenting patient self‐reports. This study examines the variation in HR‐QoL measurement tools f...

Full description

Bibliographic Details
Published in:	ESC Heart Failure
Main Authors:	Dhrumil Patil, Hsin‐Ju Tang, Fang‐Hsiu Kuo, Han Siong Toh, I‐Ning Yang, Wei‐Ting Chang, Mei‐Chuan Lee, Kai‐Ning Chung, Chi‐Ya Huang, Wan‐Hsuan Hsu, Ting‐Chia Chang, Jhih‐Yuan Shih, Chia‐Te Liao
Format:	Article
Language:	English
Published:	Wiley 2024-08-01
Subjects:	Heart failure HFrEF Quality of life Questionnaire Patient‐reported outcome
Online Access:	https://doi.org/10.1002/ehf2.14745

Similar Items

Heart failure with improved ejection fraction: patient characteristics, clinical outcomes and predictors for improvement
by: Amitai Segev, et al.
Published: (2024-07-01)

Hospitalized patients and stimulant use-associated heart failure: importance of ejection fraction and related risk factors
by: Akshat Agrawal, et al.
Published: (2025-07-01)

Left ventricular output indices and sacubitril/valsartan titration: role of stroke volume index
by: Paolo Tolomeo, et al.
Published: (2022-06-01)

The Sub-Analysis of HFmrEF and HFrEF Group in CORE-HF Registry : When being Good is Not Enough
by: Irnizarifka Irnizarifka, et al.
Published: (2023-10-01)

A Comprehensive Profile of Heart Failure Patients Across Ejection Fraction Subtypes: Insights from a Single-Center Retrospective Cohort Study
by: Austėja Kaunaitė, et al.
Published: (2025-08-01)

Differential Effects of Landiolol in Patients with Atrial Fibrillation and Atrial Tachycardia
by: Kengo Ayabe, et al.
Published: (2024-10-01)

Glycosphingolipids in Cardiovascular Disease: Insights from Molecular Mechanisms and Heart Failure Models
by: Sarah Huang, et al.
Published: (2024-10-01)

Small Heart Size and Premature Death in 366,484 Individuals With Normal Ejection Fraction
by: Stephanie J. Rowe, BBiomed, MD, et al.
Published: (2025-01-01)

Identifying plasma proteomic signatures from health to heart failure, across the ejection fraction spectrum
by: Karolina Andrzejczyk, et al.
Published: (2024-06-01)

Benefit of a wearable cardioverter defibrillator for detection and therapy of arrhythmias in patients with myocarditis
by: Verena Tscholl, et al.
Published: (2021-08-01)

Heart failure: an update from the last years and a look at the near future
by: Mauro Riccardi, et al.
Published: (2022-12-01)

Proteomic Associations of Adverse Outcomes in Human Heart Failure
by: Marie‐Joe Dib, et al.
Published: (2024-03-01)

Total-Arterial Revascularization Is Superior in Heart Failure Patients with Reduced Ejection Fraction—A Propensity Score Matched Retrospective Multicenter Analysis
by: Christian Jörg Rustenbach, et al.
Published: (2025-09-01)

The use of sacubitril/valsartan in different forms of heart failure
by: Mohammad Abumayyaleh, et al.
Published: (2025-06-01)

Intravenous iron in heart failure: still no prognostic impact, but questions remain
by: Ibrahim El-Battrawy, et al.
Published: (2025-08-01)

Association between blood eosinophil levels and prognosis in critically ill patients with different heart failure phenotypes
by: Chengjian Guan, et al.
Published: (2025-02-01)

Influence of Obesity on Short-Term Surgical Outcomes in HFrEF Patients Undergoing CABG: A Retrospective Multicenter Study
by: Christian Jörg Rustenbach, et al.
Published: (2024-02-01)

Locomotor and respiratory muscle abnormalities in HFrEF and HFpEF
by: Norman Mangner, et al.
Published: (2023-10-01)

Machine Learning-Driven Prediction of One-Year Readmission in HFrEF Patients: The Key Role of Inflammation
by: Ma F, et al.
Published: (2025-07-01)

Sex‐specific cardiovascular protein levels and their link with clinical outcome in heart failure
by: Marie deBakker, et al.
Published: (2024-02-01)

Cardiac Contractility Modulation in Patients with Heart Failure with Reduced Left Ventricular Ejection Fraction
by: Francesco Giallauria, et al.
Published: (2021-03-01)

Treatment patterns of patients with worsening heart failure with reduced ejection fraction
by: Stephen J. Greene, et al.
Published: (2024-08-01)

Long-Term Effects of Angiotensin Receptor–Neprilysin Inhibitors on Myocardial Function in Chronic Heart Failure Patients with Reduced Ejection Fraction
by: Gregor Poglajen, et al.
Published: (2020-07-01)

Sex-based differences in cardiovascular proteomic profiles and their associations with adverse outcomes in patients with chronic heart failure
by: Marie de Bakker, et al.
Published: (2023-05-01)

Correction: Adverse effects of finerenone in patients with heart failure: a systematic review and meta-analysis
by: Wanqian Yu, et al.
Published: (2025-07-01)

EVOLUTION‐HF DEallEF: A non‐interventional study of patients with heart failure initiated on dapagliflozin: study design
by: Matthias Paul, et al.
Published: (2025-08-01)

Phenotyping patients with chronic obstructive pulmonary disease and heart failure
by: Peter Moritz Becher, et al.
Published: (2025-04-01)

Adverse effects of finerenone in patients with heart failure: a systematic review and meta-analysis
by: Wanqian Yu, et al.
Published: (2025-05-01)

Novel Relaxin Receptor RXFP1 Agonist AZD3427 in the Treatment of Heart Failure: A Phase 1a/b, First‐in‐Human, Randomized, Single‐Blind, Placebo‐Controlled Study
by: Kathleen Connolly, et al.
Published: (2024-08-01)

D‐dimer and outcomes in hospitalized heart failure patients across the ejection fraction phenotypes
by: Liyan Huang, et al.
Published: (2022-10-01)

Association of Long‐Term Body Mass Index Variability With the Development of Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction Across Patterns of Weight Change
by: Zeshui Yu, et al.
Published: (2025-09-01)

Multi‐microRNA diagnostic panel for heart failure with preserved ejection fraction in preclinical and clinical settings
by: Reza Parvan, et al.
Published: (2025-08-01)

Aptamer Proteomics for Biomarker Discovery in Heart Failure With Preserved Ejection Fraction: The PARAGON‐HF Proteomic Substudy
by: Natasha L. Patel‐Murray, et al.
Published: (2024-07-01)

Real‐world clinical diagnostics of heart failure patients with reduced or preserved ejection fraction
by: Jenni Huusko, et al.
Published: (2020-06-01)

Large Animal Models of Heart Failure: Reduced vs. Preserved Ejection Fraction
by: Christopher J. Charles, et al.
Published: (2020-10-01)

Comparison of Patients with Reduced and Mildly Reduced Left Ventricular Ejection Fraction: Intermediate Data from the FAR NHL Registry
by: Alžběta Trčková, et al.
Published: (2022-10-01)

Therapeutic implications of statins in heart failure with reduced ejection fraction and heart failure with preserved ejection fraction: a review of current literature [version 1; peer review: 2 approved]
by: Chanavuth Kanitsoraphan, et al.
Published: (2021-01-01)

Exercise Mode in Heart Failure: A Systematic Review and Meta-Analysis
by: Jamie Edwards, et al.
Published: (2023-01-01)

Prognostic Value of Depressive Symptoms for Cardiovascular Events in Female Patients With Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction
by: Hengli Zhao, et al.
Published: (2024-05-01)

Proteomic biomarkers and biological pathways associated with atrial fibrillation in heart failure patients with reduced ejection fraction
by: Teun B. Petersen, MSc, et al.
Published: (2025-09-01)